CIK 0001231457
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
GENELUX Corp
Sign in to watch- Ticker
- GNLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 805-267-9889
- Business address
- 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $155,693
- in 6 filings
Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-14 | Cappello Joseph VP, Pharmaceutical Development | Grant or award | +11,557 | 20,953 | ||
| 2024-03-14 | Yu Yong VP, Clinical Trial Operations | Grant or award | +11,557 | 17,718 | ||
| 2024-03-14 | Ryder Sean General Counsel | Grant or award | +9,270 | 22,778 | ||
| 2024-03-14 | Jewett Caroline Head of Quality | Grant or award | +3,612 | 25,890 | ||
| 2024-02-19 | Zindrick Thomas President and CEO | Grant or award | +8,320 | 22,971 | ||
| 2024-02-19 | Zak Lourie S. Chief Financial Officer | Grant or award | +1,220 | 32,470 | ||
| 2024-02-19 | Smalling Ralph Head of Regulatory | Grant or award | +616 | 13,931 | ||
| 2024-02-19 | Cappello Joseph VP, Pharmaceutical Development | Grant or award | +3,661 | 9,396 | ||
| 2024-02-19 | Yu Yong VP, Clinical Trial Operations | Grant or award | +3,661 | 6,161 | ||
| 2024-02-19 | Ryder Sean General Counsel | Grant or award | +2,936 | 13,508 | ||
| 2024-02-19 | Jewett Caroline Head of Quality | Grant or award | +1,143 | 22,278 | ||
| 2023-12-15 | Yu Yong VP, Clinical Trial Operations | Sale | −26,732 | $12.94 | $346K | 5,803 |
| 2023-12-15 | Yu Yong VP, Clinical Trial Operations | Sale | −5,803 | $14.18 | $82K | 0 |
| 2023-12-13 | Tyree James L Director | Sale | −5,653 | $12.91 | $73K | 6,807 |
| 2023-12-13 | Tyree James L Director | Sale | −3,347 | $13.73 | $46K | 3,460 |
| 2023-12-13 | Thomas John Director | Sale | −7,073 | $13.23 | $94K | 465,387 |
| 2023-12-13 | Thomas John Director | Sale | −1,927 | $13.93 | $27K | 463,460 |
| 2023-12-07 | Yu Yong VP, Clinical Trial Operations | Sale | −36,800 | $11.85 | $436K | 32,535 |
| 2023-11-21 | Yu Yong VP, Clinical Trial Operations | Sale | −18,665 | $10.26 | $192K | 69,335 |
| 2023-11-20 | Yu Yong VP, Clinical Trial Operations | Sale | −14,594 | $11.26 | $164K | 88,000 |
Page 10 of 16 · 315 trades